Collplant biotechnologies unveils inaugural esg and sustainability report

Rehovot, israel , july 29, 2024 /prnewswire/ -- collplant biotechnologies (nasdaq: clgn), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced the release of its inaugural environmental, social and corporate governance (esg) and sustainability report covering 2023. the company's first report details the initiatives that collplant has taken to adopt an esg strategy with a focus on the pillars that represent the areas with the highest impact.
CLGN Ratings Summary
CLGN Quant Ranking